LEO Pharma Inc. is the U.S. affiliate of LEO Pharma A/S, an independent, research-based pharmaceutical company headquartered in Denmark. LEO Pharma Inc. officially launched in the United States in 2010 and, today, the U.S. affiliate, based in Madison, N.J., has employees located across the country in sales and medical affairs roles.
More than 330 U.S. employees work for LEO Pharma Inc. as part of a global team of 6,000 people serving 92 million patients in 130 countries.
Our company was founded in 1908 and is owned by the LEO Foundation. We have devoted decades of research and development to advance the science of dermatology, setting new standards of care for people with skin conditions.
Today, we are committed to medical and rare dermatology, and our purpose is to make a difference in the lives of people living with a skin disease. We have a robust R&D pipeline, a wide range of therapies and a pioneering spirit.